Antamina Resumes Operations
VANCOUVER, British Columbia, May 27, 2020 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) announced […]
Conduent Redesigns BenefitWallet® App to Support COVID-19 Related Government Changes to Health Accounts
FLORHAM PARK, N.J., May 27, 2020 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT) today announced the launch of its newly […]
Angkor Reports 55.4 g/t Gold from Wild Boar Sampling
TORONTO, May 27, 2020 (GLOBE NEWSWIRE) — Angkor Resources Corp. (TSXV: ANK and OTC: ANKOF) (“Angkor” or “the Company”) CEO […]
Datametrex Reports First Quarter Results
TORONTO, May 27, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is […]
Gulf Resources Announces Receipt of Final Approval for Construction of its Shouguang Yuxin Chemical Factory
SHOUGUANG, China, May 27, 2020 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (NASDAQ:GURE) (“Gulf Resources” or the “Company”), a leading manufacturer […]
Ziopharm Oncology to Present at the Jefferies 2020 Healthcare Conference on June 3, 2020
BOSTON, May 27, 2020 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief […]
MicroVision Regains Compliance with Nasdaq Market Value Listing Requirement
REDMOND, Wash., May 27, 2020 (GLOBE NEWSWIRE) — MicroVision, Inc. (Nasdaq:MVIS) announced that it has received a letter from Nasdaq […]
Genasys™ Inc. Now an Official IPAWS-OPEN Software Service Provider
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and […]
Satsuma Pharmaceuticals to To Present at the Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 27, 2020 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today […]
Turning Point Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation […]
